Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3

References

• Hideshima T, Mitsiades C, Tonon G, Richardson P G, Anderson K C. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 2007; 7: 585–598
   PubMed Web of Science ®Google Scholar
• Xu F H, Sharma S, Gardner A, Tu Y, Raitano A, Sawyers C, Lichtenstein A. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 1998; 92: 241–251
   PubMed Web of Science ®Google Scholar
• Puthier D, Bataille R, Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur J Immunol 1999; 29: 3945–3950
   PubMed Web of Science ®Google Scholar
• Ge N L, Rudikoff S. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood 2000; 96: 2856–2861
   PubMed Web of Science ®Google Scholar
• Stromberg T, Ekman S, Girnita L, Dimberg L Y, Larsson O, Axelson M, et al. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood 2006; 107: 669–678
   PubMed Web of Science ®Google Scholar
• Tu Y, Gardner A, Lichtenstein A. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 2000; 60: 6763–6770
   PubMed Web of Science ®Google Scholar
• Mitsiades C S, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 2002; 21: 5673–5683
   PubMed Web of Science ®Google Scholar
• Hideshima T, Chauhan D, Schlossman R, Richardson P, Anderson K C. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications. Oncogene 2001; 20: 4519–4527
   PubMed Web of Science ®Google Scholar
• Ghosh J C, Altieri D C. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res 2005; 11: 4580–4588
   PubMed Web of Science ®Google Scholar
• Ougolkov A V, Billadeau D D. Targeting GSK-3: a promising approach for cancer therapy?. Future Oncol 2006; 2: 91–100
   PubMedGoogle Scholar
• Tsuchiya K, Nakamura T, Okamoto R, Kanai T, Watanabe M. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3β in human colon cancer. Gastroenterology 2007; 132: 208–220
   PubMed Web of Science ®Google Scholar
• Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2001; 2: 769–776
   PubMed Web of Science ®Google Scholar
• Doble B W, Woodgett J R. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116: 1175–1186
   PubMed Web of Science ®Google Scholar
• Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359: 1–16
   PubMed Web of Science ®Google Scholar
• Shaw M, Cohen P. Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells. FEBS Lett 1999; 461: 120–124
   PubMed Web of Science ®Google Scholar
• Armstrong J L, Bonavaud S M, Toole B J, Yeaman S J. Regulation of glycogen synthesis by amino acids in cultured human muscle cells. J Biol Chem 2001; 276: 952–956
   PubMed Web of Science ®Google Scholar
• Birkenkamp K U, Coffer P J. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 2003; 31: 292–297
   PubMed Web of Science ®Google Scholar
• Dijkers P F, Medema R H, Pals C, Banerji L, Thomas N S, Lam E W, et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 2000; 20: 9138–9148
   PubMed Web of Science ®Google Scholar
• Kops G J, Medema R H, Glassford J, Essers M A, Dijkers P F, Coffer P J, Lam E W, Burgering B M. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 2002; 22: 2025–2036
   PubMed Web of Science ®Google Scholar
• Burgering B M, Medema R H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 2003; 73: 689–701
   PubMed Web of Science ®Google Scholar
• Van Der Heide L P, Hoekman M F, Smidt M P. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004; 380: 297–309
   PubMed Web of Science ®Google Scholar
• Martinez A, Alonso M, Castro A, Perez C, Moreno F J. First non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J Med Chem 2002; 45: 1292–1299
   PubMed Web of Science ®Google Scholar
• Wickrema A, Uddin S, Sharma A, Chen F, Alsayed Y, Ahmad S, et al. Engagement of Gab1 and Gab2 in erythropoietin signaling. J Biol Chem 1999; 274: 24469–24474
   PubMed Web of Science ®Google Scholar
• Falschlehner C, Emmerich C H, Gerlach B, Walczak H. TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 2007; 39: 1462–1475
   PubMed Web of Science ®Google Scholar
• Hideshima T, Nakamura N, Chauhan D, Anderson K C. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 2001; 20: 5991–6000
   PubMed Web of Science ®Google Scholar
• Maaza G-A, Uddin S, Mahmud D, Damacela I, Lavelle D, Ahmed M, et al. Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway. Biochem Biophys Res Commun 2002; 297: 760–764
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Ahmad N. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer. Toxicol Appl Pharmacol 2007; 224: 360–368
   PubMed Web of Science ®Google Scholar
• Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, et al. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clin Cancer Res 2006; 12: 5887–5894
   PubMed Web of Science ®Google Scholar
• Frelin C, Imbert V, Griessinger E, Loubat A, Dreano M, Peyron J F. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells. Oncogene 2003; 22: 8187–8194
   PubMed Web of Science ®Google Scholar
• Ni H, Ergin M, Huang Q, Qin J Z, Amin H M, Martinez R L, et al. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol 2001; 115: 279–286
   PubMed Web of Science ®Google Scholar
• Bjorkstrand B, Gahrton G. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. Semin Hematol 2007; 44: 227–233
   PubMed Web of Science ®Google Scholar
• Vescio R A, Han E J, Schiller G J, Lee J C, Wu C H, Cao J, et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant 1996; 18: 103–110
   PubMed Web of Science ®Google Scholar
• Vogel W, Kopp H G, Kanz L, Einsele H. Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation. J Cancer Res Clin Oncol 2005; 131: 214–218
   PubMed Web of Science ®Google Scholar
• Gazitt Y, Reading C C, Hoffman R, Wickrema A, Vesole D H, Jagannath S, et al. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381–389
   PubMed Web of Science ®Google Scholar
• Trowbridge J J, Xenocostas A, Moon R T, Bhatia M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat Med 2006; 12: 89–98
   PubMed Web of Science ®Google Scholar
• Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 2005; 65: 2537–2541
   PubMed Web of Science ®Google Scholar
• Goldman-Leikin R E, Salwen H R, Herst C V, Variakojis D, Bian M L, Le Beau M M, et al. Characterization of a novel myeloma cell line, MM.1. J Lab Clin Med 1989; 113: 335–345
   PubMed Web of Science ®Google Scholar
• Moalli P A, Pillay S, Weiner D, Leikin R, Rosen S T. A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 1992; 79: 213–222
   PubMed Web of Science ®Google Scholar
• Gazdar A F, Oie H K, Kirsch I R, Hollis G F. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene. Blood 1986; 67: 1542–1549
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Moore G E, Yagi Y, Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 1967; 125: 1246–1250
   PubMed Web of Science ®Google Scholar
• Nilsson K. Synthesis and secretion of IgE by an established human myeloma cell line. Clin Exp Immunol 1971; 9: 785–793
   PubMed Web of Science ®Google Scholar
• Nilsson K, Bennich H, Johansson S G, Ponten J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol 1970; 7: 477–489
   PubMed Web of Science ®Google Scholar
• Dalton W S, Durie B G, Alberts D S, Gerlach J H, Cress A E. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res 1986; 46: 5125–130
   PubMed Web of Science ®Google Scholar
• Dalton W S, Grogan T M, Meltzer P S, Scheper R J, Durie B G, Taylor C W, et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989; 7: 415–424
   PubMed Web of Science ®Google Scholar